The effect of L-carnitine on erectile dysfunction

Evaluation of the effect of adding oral vial L-carnitine on the efficacy of sildenafil citrate tablets in the treatment of erectile dysfunction in men with type 2 diabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200714048106N1

Enrollment

Registered

2020-07-29

Start date

2021-04-21

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction. Male erectile dysfunction

Interventions

Intervention 1: Intervention group: First, the form containing demographic information and the International Erection Questionnaire for patients are completed, and then they receive the sildenafil tab

Eligibility

Sex/Gender

Male

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Erectile dysfunction Diagnose type 2 diabetes for at least three months No history of taking sildenafil citrate or L-carnitine during the previous three months

Exclusion criteria

Exclusion criteria: Patients with spinal cord injury Patients treated with sildenafil citrate or L-carnitine. Severe kidney failure Known liver disease Erectile dysfunction (ED) with known and treated origin of psychological disorder

Design outcomes

Primary

Measure	Time frame
Erectile function. Timepoint: After 4 weeks. Method of measurement: International index of erectile function 5 (IIEF5).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHesam-o-din Rezae

Arak University of Medical Sciences

hesameddinrezaei13740624@gmail.com+98 86 3417 3639

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026